Project Grant R21AI190266
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $109,476 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Wisconsin-Madison on November 30, 2025, with completion scheduled for May 31, 2027. This research project focuses on understanding the molecular mechanisms underlying multidrug efflux transporter function in bacteria, specifically investigating how the NorA transporter exports...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $560,178 to the University of Wisconsin–Madison on July 25, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support investigator-initiated research examining the molecular regulatory mechanisms of Staphylococcus aureus (S. aureus) pathogenesis. The research project, entitled "FSA3 Prophage as a Molecular Regulatory Switch of Staphylococcus aureus...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $596,318 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 10, 2026 through January 31, 2031. This award supports research aimed at defining virulence factor functions in non-typhoidal Salmonella typhimurium using minimal pathogen genomes. The research employs genetically...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Wisconsin–Madison a $392,634 Project Grant effective May 13, 2025, through April 30, 2030, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds the development of a novel nanoimmunotherapeutic treatment approach targeting multidrug-resistant (MDR) bacterial infections, specifically gram-negative ESKAPE pathogens including...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Illinois a Project Grant of $154,052 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 5, 2025, with a completion date of July 31, 2027. This research project investigates the role of arginine as a metabolic cue during enteric infection, specifically examining how arginine availability in the gastrointestinal environment modulates the...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Wisconsin-Madison a $427,625 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 1, 2026, with a completion date of January 31, 2028. The grant funds research investigating the mechanisms of fallopian tube damage caused by Neisseria gonorrhoeae infection that results in pelvic inflammatory disease. The research will utilize human...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases awarded $3,085,097 to the University of Wisconsin-Madison under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 9, 2025, for research extending through June 30, 2029. This Project Grant supports scientific investigation into the role of cryptic influenza virus proteins in viral replication and pathogenesis. The research focuses on deletion-containing viral genomes (DeLVGs), which...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Wisconsin–Madison a $427,625 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period August 1, 2025 through July 31, 2027. The project focuses on developing plasmid-independent, carbohydrate-regulated production of recombinant proteins using Limosilactobacillus reuteri (LR), a probiotic human gut symbiont, as a therapeutic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $434,684 to the University of Wisconsin–Madison under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 1, 2026, for a project grant extending through January 31, 2028. The project, titled "The Impacts of Glutathione on Clostridioides difficile Infection," supports investigator-initiated biomedical research aimed at advancing scientific understanding of...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Wisconsin–Madison a Project Grant totaling $753,899 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 2, 2026, through January 31, 2031. This five-year research project will investigate the mechanisms by which butyrate, a microbiome-derived metabolite influenced by dietary fiber intake, impacts Clostridioides difficile (CD)...
The University of Wisconsin–Madison received a $427,625 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 2, 2026, with completion targeted for January 31, 2028. The award funds research to define the role of the YeiH protein in Salmonella pathogenesis, specifically investigating how this protein enables non-typhoidal Salmonella enterica (NTS) to resist sulfite-induced stress during infection. The research addresses a significant public health concern, as NTS is a leading cause of bacterial foodborne gastroenteritis and foodborne pathogen-related deaths. Sulfites, toxic reactive sulfur species produced by neutrophils during bacterial infection and present in food products as natural metabolites or preservatives, represent a critical survival challenge for enteric pathogens. The funded research comprises two primary aims designed to elucidate YeiH function in infection and sulfite stress resistance. Aim 1 establishes YeiH's role during infection using animal models of colitis and sepsis, while employing a novel YeiH transcriptional reporter as a sulfite biosensor to map tissue-specific expression patterns during enteric and systemic salmonellosis. Aim 2 determines the molecular mechanisms by which YeiH contributes to sulfite stress resistance, investigating whether the protein functions as a sulfite exporter to enable bacterial survival. These research activities will advance scientific understanding of Salmonella pathogenic mechanisms and may inform development of intervention strategies targeting this foodborne pathogen.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $427.6k | 2/2/26 |